in intermediate-grade malignant nhl , intensive therapy yield results that are as beneficial as those of mild therapy in low-grade malignant nhl ( 5-year survival rate 62 % and 65 % , respectively ) .
C0079747
low-grade malignant nhl
C0024305
nhl